¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Progesterone receptor test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • sensory receptor
    °¨°¢¼ö¿ë±â
  • silent receptor
    ¹«¹ÝÀÀ¼ö¿ëü
  • taste receptor
    ¹Ì°¢¼ö¿ë±â
  • T-cell antigen receptor
    T¼¼Æ÷Ç׿ø¼ö¿ëü
  • T-cell receptor
    T¼¼Æ÷¼ö¿ëü
  • tactile receptor
    Ã˰¢¼ö¿ë±â
  • vasopressor receptor
    Ç÷¾Ð»ó½Â¼ö¿ëü
  • visual receptor
    1. ½Ã°¢¼ö¿ë±â 2. °¨±¤Ã¼
  • volume receptor
    ¿ëÀû¼ö¿ë±â
  • acceptance test
    Àμö°Ë»ç
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦°Ë»ç
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • secretin test
    ¼¼Å©·¹Æ¾°Ë»ç
  • sentence completion test
    ¹®Àå¿Ï¼º°Ë»ç
  • statistical test
    Åë°è°ËÁ¤
  • test tube
    ½ÃÇè°ü
  • thematic apperception test
    ÁÖÁ¦Åë°¢°Ë»ç
  • tilt test
    ±â¸³°æ»ç°Ë»ç
  • treadmill test
    Æ®·¹µå¹Ð°Ë»ç
  • triple test
    »ïÁß°Ë»ç
  • triple marker test
    »ïÁßÇ¥Áö°Ë»ç
  • tuberculin test
    Åõº£¸£Ä𸰰˻ç
  • urea breath test
    ¿ä¼Ò³¯¼û°Ë»ç
  • vestibular function test
    ¾È¶ã±â´É°Ë»ç, ÀüÁ¤±â´É°Ë»ç
  • visual acuity test
    ½Ã·Â°Ë»ç
  • water deprivation test
    ¼öºÐÁ¦ÇѰ˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • tactile receptor
    Ã˰¢¼ö¿ëü
  • taste receptor
    ¹Ì°¢¼ö¿ëü
  • tension receptor
    Àå·Â¼ö¿ëü
  • vasopressor receptor
    Ç÷°ü¼öÃà¼ö¿ëü
  • visual receptor
    ½Ã°¢¼ö¿ëü, °¨±¤Ã¼
  • volume receptor
    ¿ëÀû¼ö¿ëü
  • abrasion test
    ¸¶¸ê½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • acceptance test
    Àμö°Ë»ç
  • achievement test
    ¼ºÃëµµ°Ë»ç
  • acid challenge test
    »êÅõ¿©°Ë»ç
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø°Ë»ç
  • afterimage test
    ÀÜ»ó°Ë»ç
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • RPR test => rapid plasma reagin test
    ½Å¼ÓÇ÷À帮¾ÆÁø<°¨ÀÛÇ×ü>½ÃÇè
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • acidified serum test=Ham test
    »ê¼ºÈ­Ç÷û°Ë»ç
  • acidified-serum lysis test=Ham test
    »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • antiglobulin test = Coombs test
    Çױ۷κҸ°°Ë»ç
  • polyethylene glycol test =PEG test
    Æú¸®¿¡Æ¿·»±Û¸®Äݰ˻ç
  • ACTH stimulation test
    ACTH Àڱذ˻ç
  • Ames test
    ¿¡ÀÓ½º½ÃÇè
  • Ascolis test
    ¾Æ½ºÄݸ®½ÃÇè
  • Bacitracin differential disk test
    ¹Ù½ÃÆ®¶ó½Å°¨º°(¿ø)ÆÇ(÷ù)½ÃÇè
  • Bender-Gestalt test
    º¥´õ-°Ô½´Å»Æ® °Ë»ç
  • Benedict test
    º£³×µñÆ®½ÃÇè
  • Bentonite flocculation test
    º¥Å䳪ÀÌÆ® ¸é»óħÀü¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • labyrinthine receptor
    ¹Ì·Î¼ö¿ë±â
  • maltose channel (lamda receptor)
    ¸»Å佺Åë·Î (¶÷´Ù¼ö¿ëü)
  • mmuscle receptor
    ±Ù°¨¼ö±â
  • mu receptor
    ¹Â¼ö¿ëü
  • muscarinic receptor
    ¹«½ºÄ«¸° ¼ö¿ëü
  • neuromuscular receptor
    ½Å°æ±Ù¼ö¿ëü
  • nicotinic receptor
    ´ÏÄÚÆ¾ ¼ö¿ëü
  • olfactory receptor
    Èİ¢°¨¼ö±â
  • olfactory receptor cells
    Èİ¢¼ö¿ë¼¼Æ÷
  • opiate receptor
    ¾ÆÆí¼ö¿ëü(áôé»ô÷)
  • opiate receptor
    ¾ÆÆí¼ö¿ëü.
  • opioid receptor
    ¾ÆÆí¾ç¼ö¿ëü
  • opioid receptor
    ¾ÆÆí°è¹°Áú¼ö¿ëü.
  • opioid receptor
    ¾ÆÆí¾ç¹°Áú¼ö¿ëü.
  • opioid receptor
    ¾ÆÆí¾ç¹°Áú¼ö¿ëü.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cross-agglutination test
    ±³Â÷ÀÀÁý °Ë»ç(Îßó©ëêó¢ËþÞÛ)
  • Farr test
    ÆÄ¾Æ ½ÃÇè (ãËúÐ)
  • Fehling's test
    Æç¸µ ½ÃÇè(ãËúÐ)
  • fluctuation test
    ¿äµ¿ ½ÃÇè(èôÔÑãËúÐ)
  • Fouchet's test
    Ǫ½¦ °Ë»ç(ËþÞÛ)
  • F test
    F ½ÃÇè(ãËúÐ)
  • galactose tolerance test
    °¶¶ôÅ佺 ³»¼º°Ë»ç(Ò±àõËþÞÛ)
  • glucose tolerance test
    ±Û·çÄÚ½º ³»¼º °Ë»ç(Ò±àõì×í­)
  • hapten inhibition test
    ÇÕÅÙ ÀúÇØ½ÃÇè(ãËúÐ)
  • Harris-Ray test
    ÇØ¸®½º-·¡ÀÌ ½ÃÇè(ãËúÐ)
  • Heller's test
    Çï·¯ ½ÃÇè(ãËúÐ)
  • immunoprecipitation test
    ¸é¿ªÄ§Àü ½ÃÇè(Øóæ¹öØîþãËúÐ)
  • indirect complement fixation test
    °£Á¢º¸Ã¼°íÁ¤½ÃÇè(ÊàïÈÜÍô÷ͳïÒãËúÐ)
  • indirect Coomb's test
    °£Á¢(ÊàïÈ) Äñ½ÃÇè(ãËúÐ)
  • insulin stimulating test
    Àν¶¸° ÀڱؽÃÇè(í©Ð½ãËúÐ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
MPA   1) Mean Pulmonary Artery
  2) Medroxy-Progesterone Acetate(Provera¨Þ)
&nb...
APD action potential duration; acute polycystic disease; advanced physical diagnosis; anteroposterior di...
IPCS intrauterine progesterone contraception system
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
PG paregoric; parotid gland; pentagastrin; pepsinogen; peptidoglycan; Pharmacopoeia Germanica; phosphat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
PIBF Progesterone Induced Blocking Factor
PRID Progesterone Releasing Intravaginal Device
MP micronized progesterone
PGR progesterone
PO progesterone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • allergen test
    ¾Ë·¹¸£°Õ ½ÃÇè
    ¾Ë·¹¸£±â¼º ÁúȯÀÇ ¿øÀÎÀÌ µÇ´Â ¾Ë·¹¸£°ÕÀ» °ËÃâ, È®ÀÎÇÏ´Â °Ë»ç¹ý. ½ÃÇè°ü³» ¹ÝÀÀ°ú »ýü ³» ¹ÝÀÀÀ¸·Î ³ª´¶´Ù. ½ÃÇè°ü³» ¹ÝÀÀ¿¡´Â Ç÷ûÇÐÀû ¹ÝÀÀ ¿Ü¿¡ ¹éÇ÷±¸ ¿ëü¹ÝÀÀÀ̳ª Ç÷¼ÒÆÇ ¿ëÇØ¹ÝÀÀ, È÷½ºÅ¸¹Î À¯¸®½ÃÇè, Å»°ú¸³ ½ÃÇè µîÀÌ ÀÖ´Ù. »ýü³» ¹ÝÀÀÀº, Á÷Á¢ ȯÀÚ¿¡°Ô ¾Ë·¹¸£°ÕÀ» Åõ¿©ÇÏ¿©, Áõ¼¼ÀÇ ¹ßÇöÀ» Á¶»çÇÏ´Â À¯¹ß½ÃÇè°ú, ´Ù¸¥ °Ç°­ÇÑ »ç¶÷¿¡°Ô ȯÀÚÀÇ Ç÷û, ¶Ç´Â ¹éÇ÷±¸¸¦ ÁÖ»çÇÑ ÈÄ ¾Ë·¹¸£°ÕÀ» Åõ¿©ÇÏ¿© ¹ÝÀÀÀ» º¸´Â Çǵ¿¼º Àü°¡½ÃÇèÀ¸·Î ³ª´¶´Ù. ÀüÀÚ¿¡´Â ÇǺΠ¹ÝÀÀÀ̳ª Á¡¸· ¹ÝÀÀÀÌ ÀÖ°í, ÈÄÀÚ¿¡´Â ÇÁ¶ó¿ì½º´ÏÃ÷-Äû½ºÆ®³Ê ¹ÝÀÀÀÌ ÀÖ´Ù.
  • alternate binaural loudness balance test
    ±³´ë¼º À½ Å©±â ÆòÇü ½ÃÇè, ¾çÀ̱³´ë À½ÆòÇü°Ë»ç, ¾çÀ̱³´ë¼º À½ÆòÇü °Ë»ç
  • alternate prism cover test
    ±³´ë ÇÁ¸®Áò °¡¸² °Ë»ç
  • Ames test
    ¿¡ÀÓ½º ½ÃÇè, ¿¡ÀÓ½º ½ÇÇè, µ¹¿¬º¯ÀÌ À¯¹ß ½ÃÇè
    1. ¿ÜÀμº È÷½ºÆ¼µòÀ» ÇÊ¿ä·Î ÇÏ´Â »ì¸ð³Ú¶ó ƼÇǹ¸®¿òÀÇ µ¹¿¬º¯ÀÌÁ¾À» ÀÌ¿ëÇÏ¿© È÷½ºÆ¼µòÀ» Á¦¿ÜÇÑ ¹èÁö¿¡ ½ÃÇèÇÒ È­Çй°ÁúÀ» ¿Ã·Á³õ¾Æ µ¹¿¬º¯ÀÌÁ¾ÀÌ Á¤»óÁ¾À¸·Î º¯È­½Ãų °¡´É¼ºÀÌ Å« °ÍÀ̹ǷΠ±×¸¸Å­ ¹ß¾Ï¼ºÀÌ Å©´Ù°í ÇÒ ¼ö ÀÖ´Ù. 2. ¹ß¾Ï¼º ¹°Áú ÃßÃâÀ» À§ÇÑ ½ÃÇèÀ¸·Î, È÷½ºÆ¼µò ÇÕ¼º¿¡ ÇÊ¿äÇÑ È¿¼Ò¸¦ °á¿©Çϰí ÀÖ´Â Salmonella ty
  • aminopyrine breath test
    ¾Æ¹Ì³ëÇǸ° È£Èí °Ë»ç
  • anesthetic test of pulp
    Ä¡¼ö ¸¶Ãë °Ë»ç
  • antiglobulin test
    Çױ۷κθ° °Ë»ç, Çױ۷κθ° ½ÃÇè
    ºÒ¿ÏÀü Ç×ü°¡ ÀûÇ÷±¸¿Í °áÇÕÇϸ鼭 ºñÀÀÁý¼ºÀÎ °æ¿ì, ŸÁ¾ µ¿¹°¿¡¼­ ÀÛ¼ºÇÑ Ç× IgG Ç×ü¸¦ Ãß°¡ÇÔÀ¸·Î½á ´Ù¸®°¡ ³õ¾ÆÁ® ÀÀÁý¹ÝÀÀÀÌ ¹ß»ýÇÑ´Ù. 1945³â Coombs¿¡ ÀÇÇÏ¿© Àç¹ß°ßµÈ ¹æ¹ýÀÌ¸ç »ýü ³»¿¡¼­ ÀÌ¹Ì ÀûÇ÷±¸¿Í °áÇÕÇϰí ÀÖ´Â Ç×ü¸¦ °ËÃâÇÏ´Â Á÷Á¢ ½ÃÇè°ú À¯¸®ÇØ ÀÖ´Â Ç×ü¸¦ ÀûÇ÷±¸¿Í °áÇÕ½ÃŰ°í ³ª¼­ °ËÃâÇÏ´Â °£Á¢ ½ÃÇèÀÌ ÀÖ´Ù.
  • apomorphine test
    ¾ÆÆ÷¸ð¸£ÇÉ ½ÃÇè
  • Apt test
    ¾ÐÆ® ½ÃÇè
  • arginine-insulin test
    ¾Æ¸£±â´Ñ-Àν¶¸° ½ÃÇè
  • arm to lung time test
    ÆÈ Æó ¼øÈ¯ ½Ã°£ ½ÃÇè
  • Army General Classification test
    À°±º¼º ºÐ·ù ½ÃÇè
  • arylsulfatase test
    ¾Æ¸±¼³ÆÄÅ×À̽º ½ÃÇè
  • Aschheim-Zondek test
    ¾Æ½¬ÇÏÀÓ-Á¸µ¦ ½ÃÇè
  • ascorbate cyanide test
    ¾Æ½ºÄÚ¸£ºó»ê ½Ã¾ÈÈ­¹° ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
muscarinic receptor kinase <enzyme> Phosphorylates muscarinic acetylcholine receptors and beta-adrenergic receptors
Registry number: EC 2.7.-
Synonym: muscarinic acetylcholine receptor kinase, machr kinase
(26 Jun 1999)
cyclic AMP receptor protein A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included (cyclic AMP receptors), nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of cyclic AMP-dependent protein kinases.
(12 Dec 1998)
presynaptic receptor <physiology> Receptors located on presynaptic terminals at synapses.
(05 Mar 1998)
Xiphophorus melanoma receptor kinase <enzyme> Growth factor receptor protein with an extracellular ligand binding domain and an intracellular catalytic domain
Registry number: EC 2.7.1.-
Synonym: xmrk protein
(26 Jun 1999)
selective oestrogen-receptor modulator <pharmacology> An antioestrogen which possesses some, but not all, of the actions of oestrogen. For example, raloxifene (evista) is classified as a SERM because it prevents bone loss (like oestrogen) and lowers serum cholesterol (like oestrogen) but (unlike oestrogen) does not stimulate the endometrial lining of the uterus.
Acronym: SERM
(17 Jul 2002)
hormone receptor assay A diagnostic test to determine whether a breast cancer's growth is influenced by hormones or if it can be treated with hormones.
(09 Oct 1997)
purinergic receptor <biochemistry> Receptors that use purine nucleotides (e.g. ATP) as ligands.
(18 Nov 1997)
signal recognition particle receptor Receptor for the signal recognition particle (SRP) found in the membrane of the endoplasmic reticulum. Also called docking protein. Heterodimeric, both protomers having GTP binding capacity, though dissimilar binding sites. Not until the complex of SRP, ribosome, message and nascent polypeptide chain binds to the SRP receptor is the block to further chain elongation released and concurrently the SRP is released, leaving the ribosome attached to the endoplasmic reticulum membrane. Cotranslational transport of the polypeptide delivers it into the lumen of the ER.
(18 Nov 1997)
S-receptor kinase <enzyme> Srk - s-receptor kinase; from brassica oleracea; amino acid sequence has been determined
Registry number: EC 2.7.1.-
Synonym: srk gene product
(26 Jun 1999)
steroid receptor Family of nuclear transcription factors, most of which are receptors for hormones of the steroid family, for example androgen, oestrogen, glucocorticoid, mineralocorticoid, progesterone, retinoic acid, ecdysone, thyroid hormone and the Drosophila transcription factors knirps, ultraspiracle and seven up. This family contains a conserved domain (the steroid finger motif) containing two C4 type zinc fingers.
(18 Nov 1997)
nicotinic acetylcholine receptor Integral membrane protein of the postsynaptic membrane to which acetylcholine binds. The receptor contains an integral ion channel, as a result of binding of acetylcholine, ion channels in the subsynaptic membrane are opened. at the neuromuscular junction, the nicotinic acetylcholine receptor initiates muscle contraction. Currently the best characterised ion channel protein: made of a hetero pentamer of related subunits, although a homo pentamer is functional in insects. Structural studies show that the acetylcholine binding site and the ionic channel are part of the same macromolecular unit. The nAChR mediates rapid transduction events (1ms) whereas receptors activating G-protein coupled channels operate on slower time scales (millisecond to second range).
(18 Nov 1997)
nicotinic cholinergic receptor A class of receptors responsive to acetylcholine that also are activated by nicotine; ganglionic (including the adrenal medulla) and neuromuscular receptors. Two classes exist: nicotinic-neuronal and nicotinic-muscular.
(05 Mar 2000)
NMDA receptor A type of glutamate receptor that participates in excitatory neurotransmission and also binds N-methyl-d-aspartate; may be particularly involved in the cell damage observed in individuals with Huntington's disease.
(05 Mar 2000)
N methyl D aspartate receptor <physiology> Glutamate receptor sub type (see excitatory amino acids). N methyl D aspartate receptor channels seem to be potentiated by intracellular arachidonic acid.
Acronym: NMDA
(26 Mar 1998)
quisqualate receptor <cell biology> Glutamate operated ion channel.
See: excitatory amino acid receptor channels.
(05 Feb 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á